StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Royalty revenues (standalone historical, $M) by Quarter

Royalty revenues (standalone historical, $M) ($M)

Vertex Pharmaceuticals Royalty revenues (standalone historical, $M): $1.20M in Q3 2018, down 45.5% from a year earlier. No newer figure appears in the documents we track.

Latest, Q3 2018
1.20
Period ended Sep 30, 2018
Change on a year earlier
-45.5%
2.20 in Q3 2017
History
15 quarters
Since Q1 2015
Sources
5
Documents cited below

Where the Q3 2018 figure comes from

Source: Form 10-Q (filed 2018-10-25) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRoyalty revenues (standalone historical, $M) ($M)Year on yearSource
Q3 2018Sep 30, 20181.20-45.5%Form 10-Q (filed 2018-10-25) ↗
Q2 2018Jun 30, 20181.10-62.1%Form 10-Q (filed 2018-07-26) ↗
Q1 2018Mar 31, 20181.40-12.5%Form 10-Q (filed 2018-04-27) ↗
Q4 2017Dec 31, 20171.30-66.7%Form 10-K (filed 2018-02-15) ↗
Q3 2017Sep 30, 20172.20-42.1%Form 10-Q (filed 2018-10-25) ↗
Q2 2017Jun 30, 20172.90-45.3%Form 10-Q (filed 2018-07-26) ↗
Q1 2017Mar 31, 20171.60-55.6%Form 10-Q (filed 2018-04-27) ↗
Q4 2016Dec 31, 20163.90-38.1%Form 10-K (filed 2018-02-15) ↗
Q3 2016Sep 30, 20163.80-34.5%Form 10-K (filed 2018-02-15) ↗
Q2 2016Jun 30, 20165.30+3.9%Form 10-K (filed 2018-02-15) ↗
Q1 2016Mar 31, 20163.60-47.1%Form 10-K (filed 2018-02-15) ↗
Q4 2015Dec 31, 20156.30–Form 10-K (filed 2017-02-23) ↗
Q3 2015Sep 30, 20155.80–Form 10-K (filed 2017-02-23) ↗
Q2 2015Jun 30, 20155.10–Form 10-K (filed 2017-02-23) ↗
Q1 2015Mar 31, 20156.80–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Royalty revenues (standalone historical, $M) ($M), quarterly Q1 2015–Q3 2018 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-royalty-hist

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?